biocardia Archives - Cardiovascular News

BioCardia submits 510(k) approval for Morph DNA steerable introducer sheath family

12th August 2024

BioCardia has submitted a...

CardiAMP Heart Failure Trial continues with first patient randomised in Covid-19 era

30th June 2020

BioCardia has announc...

Positive preclinical results supporting investigational new drug application for anti-inflammatory cell therapy for heart failure

11th May 2020

BioCardia has announc...

BioCardia gets FDA clearance for catheter to guide Helix delivery system

17th January 2020

BioCardia has receive...

$Early treatment with Helix system improves ejection fraction and symptoms$

Early treatment with Helix system improves ejection fraction and symptoms

11th June 2019

The Helix biotherapeu...

BioCardia submits 510(k) application to US FDA for its Avance steerable introducer for transseptal access to heart

14th December 2018

BioCardia has announc...

Mark Schwartz become vice president of Clinical Affairs at BioCardia

12th November 2018

BioCardia has announced t...

BioCardia and CellProThera to partner for clinical trial and marketing in Singapore of early stem cell therapy

1st November 2018

CellProThera and BioC...

BioCardia CardiAMP

BioCardia phase III CardiAMP trial passes interim safety analysis

29th September 2017

The independent Data ...

CardiAMP Heart Failure trial to further evaluate use of regenerative therapy in heart failure patients

19th September 2017

BioCardia has revealed th...

Transendocardial delivery results in greater myocardial stem cell therapy retention

26th May 2017

According to a study ...

First patient treated with CardiAmp cell therapy for ischaemic heart failure in Phase III trial

3rd March 2017

Johns Hopkins Medicine, B...

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy